Ekso Bionics Holdings, Inc. (EKSO)
USD 0.38
(8.54%)
USD 0.38
(8.54%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 28.91 Million USD | -29.3% |
| 2022 | 40.9 Million USD | -16.81% |
| 2021 | 49.16 Million USD | 138.7% |
| 2020 | 20.59 Million USD | -6.01% |
| 2019 | 21.91 Million USD | 24.13% |
| 2018 | 17.65 Million USD | -53.52% |
| 2017 | 37.98 Million USD | 55.53% |
| 2016 | 24.42 Million USD | -24.14% |
| 2015 | 32.19 Million USD | -3.81% |
| 2014 | 33.47 Million USD | 114635.22% |
| 2013 | 29.17 Thousand USD | 245.55% |
| 2012 | 8443.00 USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 29.2 Million USD | 8.25% |
| 2024 Q2 | 26.98 Million USD | -6.81% |
| 2024 Q1 | 28.95 Million USD | 0.13% |
| 2023 Q2 | 33.98 Million USD | -8.4% |
| 2023 Q4 | 28.91 Million USD | -7.26% |
| 2023 FY | 28.91 Million USD | -29.3% |
| 2023 Q1 | 37.1 Million USD | -9.29% |
| 2023 Q3 | 31.18 Million USD | -8.25% |
| 2022 Q1 | 44.24 Million USD | -10.02% |
| 2022 Q4 | 40.9 Million USD | 4.05% |
| 2022 Q3 | 39.31 Million USD | -2.98% |
| 2022 FY | 40.9 Million USD | -16.81% |
| 2022 Q2 | 40.52 Million USD | -8.41% |
| 2021 Q4 | 49.16 Million USD | -3.09% |
| 2021 Q1 | 56.5 Million USD | 174.33% |
| 2021 FY | 49.16 Million USD | 138.7% |
| 2021 Q3 | 50.73 Million USD | -4.23% |
| 2021 Q2 | 52.97 Million USD | -6.25% |
| 2020 Q3 | 23.48 Million USD | 5.09% |
| 2020 Q2 | 22.34 Million USD | 31.9% |
| 2020 FY | 20.59 Million USD | -6.01% |
| 2020 Q4 | 20.59 Million USD | -12.3% |
| 2020 Q1 | 16.94 Million USD | -22.68% |
| 2019 Q4 | 21.91 Million USD | 8.0% |
| 2019 FY | 21.91 Million USD | 24.13% |
| 2019 Q3 | 20.29 Million USD | -20.68% |
| 2019 Q2 | 25.58 Million USD | 22.64% |
| 2019 Q1 | 20.86 Million USD | 18.15% |
| 2018 Q2 | 23.2 Million USD | -25.04% |
| 2018 Q1 | 30.95 Million USD | -18.5% |
| 2018 Q4 | 17.65 Million USD | -21.26% |
| 2018 FY | 17.65 Million USD | -53.52% |
| 2018 Q3 | 22.42 Million USD | -3.38% |
| 2017 Q4 | 37.98 Million USD | -12.48% |
| 2017 Q1 | 16.89 Million USD | -30.83% |
| 2017 Q3 | 43.4 Million USD | 129.27% |
| 2017 FY | 37.98 Million USD | 55.53% |
| 2017 Q2 | 18.93 Million USD | 12.06% |
| 2016 Q1 | 22.55 Million USD | -29.96% |
| 2016 Q2 | 13.57 Million USD | -39.8% |
| 2016 Q4 | 24.42 Million USD | 12.97% |
| 2016 Q3 | 21.62 Million USD | 59.27% |
| 2016 FY | 24.42 Million USD | -24.14% |
| 2015 Q3 | 22.12 Million USD | -17.77% |
| 2015 Q2 | 26.9 Million USD | -10.41% |
| 2015 Q1 | 30.03 Million USD | -10.28% |
| 2015 FY | 32.19 Million USD | -3.81% |
| 2015 Q4 | 32.19 Million USD | 45.52% |
| 2014 Q4 | 33.47 Million USD | 117.11% |
| 2014 Q2 | 18.59 Million USD | -14.69% |
| 2014 Q1 | 21.8 Million USD | 27949969.23% |
| 2014 FY | 33.47 Million USD | 114635.22% |
| 2014 Q3 | 15.41 Million USD | -17.1% |
| 2013 Q2 | 1931.00 USD | -93.38% |
| 2013 Q4 | 78.00 USD | -82.19% |
| 2013 FY | 29.17 Thousand USD | 245.55% |
| 2013 Q1 | 29.17 Thousand USD | -2.59% |
| 2013 Q3 | 438.00 USD | -77.32% |
| 2012 Q2 | 5229.00 USD | 0.0% |
| 2012 FY | 8443.00 USD | 0.0% |
| 2012 Q4 | 29.95 Thousand USD | 135.33% |
| 2012 Q3 | 12.72 Thousand USD | 143.39% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 180.36 Million USD | 83.967% |
| AngioDynamics, Inc. | 317.67 Million USD | 90.897% |
| AtriCure, Inc. | 613.93 Million USD | 95.29% |
| Avinger, Inc. | 13.77 Million USD | -110.007% |
| Azenta, Inc. | 2.88 Billion USD | 98.998% |
| BioLife Solutions, Inc. | 412.71 Million USD | 92.993% |
| The Cooper Companies, Inc. | 11.65 Billion USD | 99.752% |
| Daxor Corporation | 34.86 Million USD | 17.067% |
| Femasys Inc. | 27.75 Million USD | -4.187% |
| GlucoTrack, Inc. | 4.9 Million USD | -489.562% |
| Harvard Bioscience, Inc. | 137.36 Million USD | 78.948% |
| Hologic, Inc. | 9.15 Billion USD | 99.684% |
| ICU Medical, Inc. | 4.37 Billion USD | 99.34% |
| Intuitive Surgical, Inc. | 15.44 Billion USD | 99.813% |
| KORU Medical Systems, Inc. | 28.46 Million USD | -1.606% |
| LeMaitre Vascular, Inc. | 346.77 Million USD | 91.661% |
| Innovative Eyewear, Inc. | 6.21 Million USD | -365.012% |
| Innovative Eyewear, Inc. | 6.21 Million USD | -365.012% |
| Masimo Corporation | 3.04 Billion USD | 99.049% |
| Microbot Medical Inc. | 8.32 Million USD | -247.28% |
| Meihua International Medical Technologies Co., Ltd. | 171.91 Million USD | 83.179% |
| Merit Medical Systems, Inc. | 2.32 Billion USD | 98.756% |
| Nephros, Inc. | 11.86 Million USD | -143.807% |
| NovoCure Limited | 1.14 Billion USD | 97.477% |
| NEXGEL, Inc. | 9.95 Million USD | -190.487% |
| NEXGEL, Inc. | 9.95 Million USD | -190.487% |
| Singular Genomics Systems, Inc. | 265.46 Million USD | 89.107% |
| OraSure Technologies, Inc. | 482.84 Million USD | 94.011% |
| Pro-Dex, Inc. | 54.21 Million USD | 46.656% |
| Pulse Biosciences, Inc. | 60.8 Million USD | 52.441% |
| Predictive Oncology Inc. | 14.41 Million USD | -100.579% |
| Precision Optics Corporation, Inc. | 16.91 Million USD | -70.985% |
| QuidelOrtho Corporation | 8.56 Billion USD | 99.662% |
| Repligen Corporation | 2.82 Billion USD | 98.976% |
| Sanara MedTech Inc. | 73.87 Million USD | 60.853% |
| STAAR Surgical Company | 488.69 Million USD | 94.083% |
| Sharps Technology, Inc. | 11.78 Million USD | -145.291% |
| Utah Medical Products, Inc. | 135.45 Million USD | 78.652% |
| DENTSPLY SIRONA Inc. | 7.37 Billion USD | 99.608% |
| Jin Medical International Ltd. | 32.9 Million USD | 12.113% |